Does low-dose aspirin lower risk of dementia in T2DM?
3' education - Nov. 16, 2021 - Prof. Jane Armitage - Oxford, UKEducational information
This video was recorded during the American Heart Association’s Scientific Sessions 2021.
Faculty
Jane Armitage is Professor of Clinical Trials and Epidemiology and Honorary Consultant in Public Health Medicine. In addition, she is Director of Training and Career Development for the Nuffield Department of Population Health.
Disclosures
This recording was independently developed under auspices of EPCCS.org. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of EPCCS.org.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: